Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tsukagoshi

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Clinical evaluation of ondansetron (injection of a single intravenous dose) against nausea and emesis associated with anti-cancer drugs--dose-finding study in patients receiving cisplatin]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Examination of anti-emetic effect, safety and usefulness of single oral dose of ondansetron tablet in nausea and emesis induced by anti-cancer drugs--dose-finding study of ondansetron tablet in patients receiving non-platinum anti-cancer drugs]N Nukariya, H Niitani, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo]Y Ariyoshi, K Ota, T Taguchi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
In vivo activity on murine tumors of a novel antitumor compound, N-beta-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190)S Nakaike, T Yamagishi, K Samata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1991
[Phase I study of CI-898. CI-898 Study Group]T Taguchi, S Tsukagoshi, H Furue, et al.
Journal of Medicinal Chemistry|June 1, 1989
Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1M Yamato, Y Takeuchi, K Hashigaki, et al.
Cancer Research|January 1, 1986
Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublinesT Tsuruo, T Oh-hara, H Iida, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1997
Antitumor activity of TZT-1027, a novel dolastatin 10 derivativeM Kobayashi, T Natsume, S Tamaoki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1996
[LY188011 phase I study. Research Group of Gemcitabine (LY188011)]T Taguchi, K Furuse, M Fukuoka, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Clinical evaluation of ondansetron (injection of a single intravenous dose) against nausea and emesis associated with anti-cancer drugs--dose-finding study in patients receiving cisplatin]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Examination of anti-emetic effect, safety and usefulness of single oral dose of ondansetron tablet in nausea and emesis induced by anti-cancer drugs--dose-finding study of ondansetron tablet in patients receiving non-platinum anti-cancer drugs]N Nukariya, H Niitani, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo]Y Ariyoshi, K Ota, T Taguchi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
In vivo activity on murine tumors of a novel antitumor compound, N-beta-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190)S Nakaike, T Yamagishi, K Samata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1991
[Phase I study of CI-898. CI-898 Study Group]T Taguchi, S Tsukagoshi, H Furue, et al.
Journal of Medicinal Chemistry|June 1, 1989
Synthesis and antitumor activity of fused tetracyclic quinoline derivatives. 1M Yamato, Y Takeuchi, K Hashigaki, et al.
Cancer Research|January 1, 1986
Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublinesT Tsuruo, T Oh-hara, H Iida, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1997
Antitumor activity of TZT-1027, a novel dolastatin 10 derivativeM Kobayashi, T Natsume, S Tamaoki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1996
[LY188011 phase I study. Research Group of Gemcitabine (LY188011)]T Taguchi, K Furuse, M Fukuoka, et al.
Pageof 18